Black Rock Inc. Ironwood Pharmaceuticals Inc Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 24,157,768 shares of IRWD stock, worth $149 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,157,768
Previous 25,980,308
7.02%
Holding current value
$149 Million
Previous $297 Million
29.2%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding IRWD
# of Institutions
296Shares Held
170MCall Options Held
27.1MPut Options Held
2.28M-
Vanguard Group Inc Valley Forge, PA19.5MShares$120 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$101 Million24.97% of portfolio
-
State Street Corp Boston, MA13.9MShares$85.9 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA7.21MShares$44.5 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny7.1MShares$43.8 Million0.1% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $945M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...